Seroquel: Big Pharma makes more money off those w/ mental health concerns than do the mental health providers: AMAZING
St. Petersburg Times
Seroquel maker wants to seal info from you, "for" youBy Kris HundleyIn Print: Sunday, February 15, 2009
"....Dr. David Egilman, facing possible criminal charges, admitted in writing that he violated a court order to keep Lilly documents secret.
"They don't want anybody to know about the side effects of their drug, and they're keeping secret the results of studies from patients, their doctors and the FDA,'' said Dr. David Egilman, clinical associate professor at Brown University's Department of Community Health.
"Saying they're protecting the patient is a self-serving, fraudulent argument."• • •
Though Egilman is merely an observer of the Seroquel proceedings, he knows the power of sealed documents in drug liability cases. He played a key role when similar lawsuits were lodged against another mega-selling antipsychotic, Eli Lilly's drug Zyprexa. As in the Seroquel cases, thousands upon thousands of patients claimed Zyprexa caused weight gain and diabetes...."
http://www.tampabay.com/news/health/article976067.ece
************************************
Philadelphia InquirerRuling near on privacy issues in Seroquel caseBy Miriam Hill
Feb. 25, 2009
Source: http://www.philly.com/inquirer/breaking/business_breaking/20090225_
Ruling_near_on_privacy_issues_in_Seroquel_case.html
And what about details of sexual relationships between Wayne Macfadden, AstraZeneca's former U.S. medical director for Seroquel, and two women who researched and wrote papers supporting the drug's safety and efficacy?
A federal judge in Orlando may answer those questions as soon as tomorrow in a case stemming from personal-injury claims by 15,000 people that Seroquel triggered weight gain, diabetes, and other health problems.
Plaintiffs' attorneys and Bloomberg News, the news organization, have sued to force London-based AstraZeneca P.L.C. to make public documents discovered in the litigation. AstraZeneca's U.S. headquarters are in Wilmington."This is, first and foremost, a public-safety issue," said Howard Nations, chairman of the Seroquel litigation group of the American Association for Justice (formerly the Association of Trial Lawyers of America).Patients, Nations said, have the right to know about safety concerns raised in discussions between AstraZeneca and the U.S. Food and Drug Administration or in unpublished research on the drug.Seroquel belongs to a class of drugs known as atypical antipsychotics.
The drug is approved to treat bipolar disorder and schizophrenia, but doctors have been prescribing it and similar drugs for conditions including attention-deficit disorder and sleeplessness.Seroquel is now one of AstraZeneca's best-selling drugs, with $4.5 billion in sales last year...."
*********************************************************************
Comments: 15
TheHammer (aka Marsha V. Hammond, PhD: comment to the Charlotte Observer documenting how the NC State Legislature can't find its way to make Big Pharma more responsible):
wrote on 06/14/2009
Good ole Seroquel: very common to see in my clients 50-100 pounds of weight gain, commonly leading to diabetes. STUN drug.
Fortunately, psychiatrists seem to be returning to some of the older medications (OOPS: no money in those drugs who have gone out from under their patent after 7 years) even if there is a risk of tardive dyskenisia.
What a mess mental health is: from A to Z.
http://www.charlotteobserver.com/408/story/772372.html
*************************************************************************
"Such a move would be opposed by the drug industry, which prefers voluntary measures such as having state officials encourage doctors to prescribe more generics.
Officials at GlaxoSmithKline declined to be interviewed for this story, but a spokeswoman for North Carolina's largest drugmaker issued a statement saying preferred drug lists interfere with the individual relationship between a doctor and a patient.
GSK employs about 5,000 people in Research Triangle Park. Besides being the state's largest pharmaceutical employer, the company is the largest political contributor among N.C. drug companies. Between 2004 and 2008, Glaxo's political action committee and executives contributed at least $218,940 to state candidates. Other drug company PACs and executives contributed at least $456,205 in the same period.
Drug companies are a formidable presence at the General Assembly.
“They are like tobacco companies,” said Rep. Verla Insko, an Orange County Democrat and budget writer. “They are a major part of our industrial base.”
Insko said there was scant support for a preferred drug list until last week, when budget writers learned they had to trim an additional $254million from Medicaid. ..."
Seroquel maker wants to seal info from you, "for" youBy Kris HundleyIn Print: Sunday, February 15, 2009
"....Dr. David Egilman, facing possible criminal charges, admitted in writing that he violated a court order to keep Lilly documents secret.
"They don't want anybody to know about the side effects of their drug, and they're keeping secret the results of studies from patients, their doctors and the FDA,'' said Dr. David Egilman, clinical associate professor at Brown University's Department of Community Health.
"Saying they're protecting the patient is a self-serving, fraudulent argument."• • •
Though Egilman is merely an observer of the Seroquel proceedings, he knows the power of sealed documents in drug liability cases. He played a key role when similar lawsuits were lodged against another mega-selling antipsychotic, Eli Lilly's drug Zyprexa. As in the Seroquel cases, thousands upon thousands of patients claimed Zyprexa caused weight gain and diabetes...."
http://www.tampabay.com/news/health/article976067.ece
************************************
Philadelphia InquirerRuling near on privacy issues in Seroquel caseBy Miriam Hill
Feb. 25, 2009
Source: http://www.philly.com/inquirer/breaking/business_breaking/20090225_
Ruling_near_on_privacy_issues_in_Seroquel_case.html
And what about details of sexual relationships between Wayne Macfadden, AstraZeneca's former U.S. medical director for Seroquel, and two women who researched and wrote papers supporting the drug's safety and efficacy?
A federal judge in Orlando may answer those questions as soon as tomorrow in a case stemming from personal-injury claims by 15,000 people that Seroquel triggered weight gain, diabetes, and other health problems.
Plaintiffs' attorneys and Bloomberg News, the news organization, have sued to force London-based AstraZeneca P.L.C. to make public documents discovered in the litigation. AstraZeneca's U.S. headquarters are in Wilmington."This is, first and foremost, a public-safety issue," said Howard Nations, chairman of the Seroquel litigation group of the American Association for Justice (formerly the Association of Trial Lawyers of America).Patients, Nations said, have the right to know about safety concerns raised in discussions between AstraZeneca and the U.S. Food and Drug Administration or in unpublished research on the drug.Seroquel belongs to a class of drugs known as atypical antipsychotics.
The drug is approved to treat bipolar disorder and schizophrenia, but doctors have been prescribing it and similar drugs for conditions including attention-deficit disorder and sleeplessness.Seroquel is now one of AstraZeneca's best-selling drugs, with $4.5 billion in sales last year...."
*********************************************************************
Comments: 15
TheHammer (aka Marsha V. Hammond, PhD: comment to the Charlotte Observer documenting how the NC State Legislature can't find its way to make Big Pharma more responsible):
wrote on 06/14/2009
Good ole Seroquel: very common to see in my clients 50-100 pounds of weight gain, commonly leading to diabetes. STUN drug.
Fortunately, psychiatrists seem to be returning to some of the older medications (OOPS: no money in those drugs who have gone out from under their patent after 7 years) even if there is a risk of tardive dyskenisia.
What a mess mental health is: from A to Z.
http://www.charlotteobserver.com/408/story/772372.html
*************************************************************************
"Such a move would be opposed by the drug industry, which prefers voluntary measures such as having state officials encourage doctors to prescribe more generics.
Officials at GlaxoSmithKline declined to be interviewed for this story, but a spokeswoman for North Carolina's largest drugmaker issued a statement saying preferred drug lists interfere with the individual relationship between a doctor and a patient.
GSK employs about 5,000 people in Research Triangle Park. Besides being the state's largest pharmaceutical employer, the company is the largest political contributor among N.C. drug companies. Between 2004 and 2008, Glaxo's political action committee and executives contributed at least $218,940 to state candidates. Other drug company PACs and executives contributed at least $456,205 in the same period.
Drug companies are a formidable presence at the General Assembly.
“They are like tobacco companies,” said Rep. Verla Insko, an Orange County Democrat and budget writer. “They are a major part of our industrial base.”
Insko said there was scant support for a preferred drug list until last week, when budget writers learned they had to trim an additional $254million from Medicaid. ..."
posted by Marsha V. Hammond, PhD at 1:53 AM
0 Comments:
Post a Comment
<< Home